ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


 News | News By Subject | News By Date | Search News
Get Our Industry eNewsletter FREE email:    
 News By Date

SuMoTuWeThFrSa
2829301234
567891011
12131415161718
19202122232425
2627282930311
2345678

 Wednesday, October 22, 2014
 Top Breaking News
 Featured Stories
 More News
Santen Announces Positive Outcome Of The European Decentralized Procedure For Approval Of TAPTIQOM®
Ferring Pharmaceuticals: CORTIMENT® MMX®, A New Treatment For Ulcerative Colitis, Receives European Approval
Alkermes plc (ALKS)’ New Drug Application For Aripiprazole Lauroxil For Treatment Of Schizophrenia Accepted For Filing By U.S. FDA
Synageva BioPharma (GEVA) Starts Rolling Submission Of A Biologics License Application To The FDA For Sebelipase Alfa
Relypsa, Inc. (RLYP) Submits New Drug Application To U.S. FDA Seeking Approval For Patiromer For Oral Suspension To Treat Hyperkalemia
Repros Therapeutics Inc. (RPRX) Release: Results From Long-Term Study Of Androxal® Exhibit Positive Safety Profile
Immune Pharmaceuticals, Inc. Release: New Clinical Data Supports Development Of Bertilimumab In Both Ulcerative Colitis And Crohn's Disease
GW Pharmaceuticals Announces Epidiolex® Receives Orphan Designation From European Medicines Agency For The Treatment Of Dravet Syndrome
Oramed Pharmaceuticals Inc. (ORMP) Reports Positive Top-Line Data From U.S. Phase 2a Trial With Oral Insulin In Type 1 Diabetes
Nuvo Research Inc. (NRI.TO) Completes WF10™ U.S. Market Study For Treatment Of Refractory Allergies
Atara Biotherapeutics (ATRA) Doses First Patient In Phase 1 Clinical Study Of STM 434, An Activin Inhibitor
iCo Therapeutics Inc. Announces Advancement Of Oral Amphotericin B Program
Phosplatin Therapeutics Announces First Patients Enrolled In Phase I First-in-Human Clinical Trial In Solid Tumors
University of Pittsburgh Study: Air Pollution Linked To Autism In Southwestern Pennsylvania
Profectus BioSciences, Inc. Receives $8.6 Million HHS Contract To Accelerate Ebola Vaccine Into Human Clinical Studies
Profectus BioSciences, Inc. Receives Department Of The Army Funding For Studies Directed Toward The Development Of A VesiculoVax™ rVSV-Vectored Vaccine For Ebola And Marburg Viruses
Tekmira (TKMR) Provides Periodic Update On TKM-Ebola Program
Immunomedics, Inc. (IMMU) To Present Updated Clinical Results With Solid-Tumor Antibody-Drug Conjugates At Upcoming Conferences